Posted by Michael Wonder on 03 May 2024
Enhertu to get insurance coverage for metastatic breast/stomach cancer from April
29 March 2024 - Starting next month, health insurance benefits will be applied to treating metastatic breast and gastric cancers with Enhertu (trastuzumab deruxtecan) in Korea.
On Thursday, the Ministry of Health and Welfare convened the Health Insurance Policy Deliberation Committee and approved the revised “Drug Reimbursement List and Benefit Limit Amount Table” to this effect.
